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Treatment Options for Pediatric Patent Ductus
Arteriosus
Systematic Review and Meta-analysis
Jennifer Y. Lam, MD; Steven R. Lopushinsky, MD; Irene W. Y. Ma, MD, PhD; Frank Dicke, MD, MBA;
and Mary E. Brindle, MD, MPH

Patent ductus arteriosus (PDA) in the nonpremature pediatric patient is currently treated by surgical ligation or catheter occlusion. There is no clear superiority of one
technique over the other. This meta-analysis compares the clinical outcomes of the two treatment options for PDA.
BACKGROUND:

We performed a literature search of MEDLINE, Embase, PubMed, and the
Cochrane database of randomized controlled trials (RCTs) that took place between 1950 and
February 2014 and hand-searched references from included studies. We excluded studies
of adult or premature patients and those without a direct comparison between surgical and
catheter-based treatments of PDAs. Outcomes of interest were reintervention, total complications, length of stay, and cost.

METHODS:

One thousand three hundred thirty-three manuscripts were screened. Eight
studies fulfilled the inclusion criteria (one RCT and seven observational studies [N 5 1,107]).
In pooled observational studies, there were significantly decreased odds (OR, 0.12; 95% CI,
0.03-0.42) for reintervention in the surgical ligation group but insignificantly higher odds for
overall complications (OR, 2.01; 95% CI, 0.68-5.91). There were no complications reported in
the RCT, but surgical ligation was associated with decreased odds for reintervention and a
longer length of stay. Funnel plots revealed a possible publication bias and a quality review
identified comparability bias.

RESULTS:

Both therapies have comparable outcomes. Reintervention is more common
with catheter-based treatment, but overall complication rates are not higher and hospital stay
is shorter. Our data span . 2 decades and may not reflect current surgical and catheterization
outcomes. Large, randomized, prospective studies may help determine the optimal treatment
CHEST 2015; 148(3):784-793
strategy.

CONCLUSIONS:
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Patent ductus arteriosus (PDA) is one of the most
common congenital heart diseases.1 Although small
PDAs may be asymptomatic, larger ones can result in
clinically significant complications.1 PDAs that are
large, symptomatic, or persistent despite medical
therapy require procedural intervention. Thoracotomy
has remained the standard for treating PDAs since it
was first performed in 1938.2,3
In recent years, minimally invasive methods to obliterate PDA have been developed. Video-assisted thoracoscopic surgery (VATS) was applied to the treatment

Materials and Methods
We followed the guidelines outlined by the Preferred Reporting Items
for Systematic Reviews and Meta-Analyses (PRISMA) statement10
(e-Appendix 1). The meta-analysis was performed using the methodology suggested by the Meta-analysis of Observational Studies in
Epidemiology (MOOSE) group.11
We performed a systematic search of all articles from 1950 to February
20, 2014, in MEDLINE, Embase, PubMed, and the Cochrane Central
Register of Controlled Trials. Our search strategy included the terms
Pediatr* OR child* OR neonate* OR infant AND PDA OR patent ductus
AND Trans-catheter OR occlusion OR coil* OR clip OR radiologic OR
interventional OR device OR surgery OR ligation OR suture including
MeSH headings of patent ductus and surgery. The full search strategy
can be seen in e-Appendix 2. A hand search of references from included
studies was performed to identify additional publications. No language
restrictions were placed, and non-English papers were translated. The
authors attempted to contact authors to retrieve missing data when
necessary to determine whether the article met the inclusion/exclusion
criteria or for data abstraction.
Study titles, abstracts, and full articles were reviewed independently by
two authors (J. Y. L. and M. E. B.) for inclusion. Disagreements were
resolved by consensus. Studies were included if there was a direct
comparison between surgical ligation and catheter-based therapies for
PDAs in the pediatric population. Studies were excluded if they had
fewer than four subjects or if they examined preterm infants or adult
patients without a population of nonpremature pediatric patients that
could be analyzed separately. Studies were also excluded if they contained duplicate or nonoriginal data, animal subjects, a lack of direct

Results
The electronic search yielded 1,333 articles. After duplicates were removed, 711 studies remained (Fig 1). We
excluded 638 papers based on review of titles, and an
additional 54 papers on review of abstracts (k 5 0.86
and 0.83, respectively). An additional five studies were
identified based on a hand search of included study
references, resulting in a total of 24 studies. The full texts
of these articles were evaluated in detail, and 16 studies
were excluded (k 5 1). Eight studies met the inclusion
criteria and were included in the analysis (one RCT
and seven observational cohort studies), for a total of
1,107 children (Fig 1).15-22
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of PDAs in 1991.4 Cardiac catheterization, first used to
treat PDAs in 1966,5 now delivers a variety of devices
for PDA occlusion.6-9 Few have studied these devices
in comparison with surgical ligation. Although preterm infants are too small for the use of transcatheter
approaches, controversy remains as to which management option is optimal for the rest of the pediatric population. In this systematic review, we examine all studies
with direct comparisons between surgical ligation and
transcatheter approaches for PDA closure in nonpremature children.

comparison between the interventions, or an absence of clinical outcomes, or if separate/missing data were not available despite attempts
to contact authors. All comparative study designs were considered.
The primary outcome of interest was residual or recurrent PDA requiring repeat intervention. Secondary outcome measures included complications, hospital length of stay (LOS), length of procedure, and
cost of intervention. We converted reported costs into United States
dollars using historical exchange rates.12 Because the studies spanned
a number of years, we used the exchange rate on the median date of
data collection.
Two reviewers (J. Y. L. and M. E. B.) independently extracted data using
a standardized form (e-Appendix 3). Data collected included publication date, country and institute where the study was performed, dates
of data collection, study design, number of cases, intervention type, age
of the patients, and size of the PDAs, as well as data on primary and
secondary outcomes. Three reviewers (J. Y. L., S. R. L., and M. E. B.)
analyzed the design and methodologic quality of included studies using
the Newcastle-Ottawa Quality Assessment Scale for cohort studies and
the Jadad scale for reporting randomized controlled trials (RCTs) to
evaluate for the risk of bias.13,14
Agreement in title, abstract, and article inclusion was reported using
Cohen’s k statistic. For outcome measures, ORs of observational studies
were pooled for both total complication rates and reintervention rates
using a random effects model.
Publication bias was assessed by inspecting for asymmetry in the Begg’s
funnel plots and by performing Egger’s test for publication bias. All
analyses were performed using Stata 13 (StataCorp LP).

Study characteristics are summarized in Table 1. We
identified one RCT performed at a single center in
Vietnam.22 In this study, 100 patients were randomized
equally to either VATS surgical ligation or catheter-based
treatment with either the Amplatzer occluder or flipper
coils based on PDA size. In the seven observational
cohort studies, 1,007 children were treated for PDA.15-21
Of these, 590 children underwent surgical ligation (65 by
VATS and 525 by thoracotomy), whereas 417 children
were treated with catheter-based therapy (192 with
Gianturco coils, 20 with Amplatzer occluders, and 205
with the Rashkind double-umbrella system). Patient age
ranged from a few days of age to 18 years. All studies
785

patients treated with either surgical ligation or catheterbased therapy.20,21 In a pooled analysis of the observational
studies, decreased odds of reintervention was associated
with surgical ligation compared with catheter-based
therapy for PDA (OR, 0.12; 95% CI, 0.03-0.42; P 5 .001).
These studies demonstrated low heterogeneity, with
an I2 of 14.4% (P 5 .32) (Fig 2). In the RCT, no patients
in the surgical arm required reintervention, compared
with three patients in the catheter-based treatment
arm.22

Figure 1 – Flow diagram of study identification, inclusion, and
exclusion. k agreement between reviewers (J. Y. L. and M. E. B.).

excluded patients with other significant comorbidities/
cardiac anomalies.
In the RCT, randomization was completed using shuffled
sealed envelopes. No attempt was made at blinding, and
all patients were accounted for in follow-up.
Of the observational studies, only one study by Dutta et al20
had appropriate comparability between interventions,
matching patients by age, sex, weight, and PDA diameter.
Four studies reported adequate accountability of their
patients in follow-up and adequate follow-up strategy
using echocardiography to document residual or
recurrent PDA,18-21 whereas five studies had adequate
follow-up length.17-21 The two multicenter studies lost
points for drawing patients treated with catheter-based
therapy from a different community than that of the
surgically treated group (Table 2).15,20 No studies attempted
to control for confounding through regression analyses,
although stratification was performed in the study by
Dutta et al.20
Evidence of publication bias was present in these studies.
Asymmetry was apparent in Begg’s funnel plots for
both reintervention and total complications. For reintervention, Egger’s test shows significant publication bias
for reintervention (0.05) but not for complication rates
(0.11).
In the observational studies, two of the 590 patients in
the surgical ligation group required reintervention for
persistent/recurrent PDA, one originally treated by
VATS approach and one by thoracotomy; 32 of the
417 patients in the catheter-based group required
reintervention, 20 of the 205 with the Rashkind doubleumbrella system (9.8%), and 12 of the 192 with Gianturco
coils (6.3%). Two studies reported no reintervention in
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Complications were defined as any clinically important
complication directly related to the procedure itself.
Examples for the surgery group included recurrent
laryngeal nerve injury, need for chest tube (chylothorax,
pneumothorax, or other), and diaphragmatic paralysis.
Catheter-based complications included embolization
with further complications (beyond reintervention) and
vascular injuries. Need for transfusion and infection
were reported in both groups.
In the observational studies, complications occurred in
85 of 590 patients in the surgical treatment arm and
44 of 417 patients treated with catheter-based therapy.
In pooled analysis, there was a nonsignificant increase
in the odds of complications associated with surgical
therapy (OR, 2.01; 95% CI, 0.68-5.91; P 5 .21). There
was moderate heterogeneity in these studies, with an I2
of 54.6% (P 5 .066) (Fig 3). In the RCT, no complications were seen in either treatment group.22
Of the observational studies, six reported LOS.15,16,18-21
As with the RCT, in the observational studies, surgical
patients had a longer LOS (Table 3).
Four of the eight studies reported the procedure time
for both interventions. In two studies, the total operative
time for surgical ligation exceeded the total procedural
time for catheter-based therapy.20,22 In the other two
studies, the opposite was true.15,18 In both studies in
which surgical ligation time exceeded catheter procedural
time, surgical ligation was performed using a VATS
approach (Table 3).
In seven studies, costs were estimated for both interventions. There was a great deal of variability in the
results. Three studies showed increased costs with
surgery,17,20,21 whereas two studies reported greater
costs with catheter-based approaches.15,22 Two studies
showed almost no difference in cost between the two
interventions (Table 4).16,18 All studies reported the cost
of providing treatment as opposed to prices charged
for services.
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Centers include The Hospital for Sick Children, Toronto, ON, Canada; Yale University School of Medicine, New Haven, CT; University of Nebraska Medical Center, Omaha, NE; Children’s Hospital, Boston, MA; Texas
Children’s Hospital, Houston, TX; Children’s Hospital of Philadelphia, Philadelphia, PA; University of Minnesota Hospital, Minneapolis, MN; University of Michigan Hospitals, Ann Arbor, MI; IWK Children’s Hospital,
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Medical Center, San Francisco, CA; UCLA Medical Center, Los Angeles, CA.
bCenters include The Hospital for Sick Children, Toronto, and McMaster Children’s Hospital, Hamilton, ON, Canada.
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Two of the observational studies examined patients
treated with VATS.19,20 In total, 65 patients were treated
by VATS, with one requiring reintervention; nine of
the 147 patients treated with catheter-based therapy
required reintervention. Three of the 65 patients treated
with VATS had documented complications, compared
with one patient in the catheter-based therapy cohort.

Discussion

Representativeness
of Cohort (1)

Ascertainment of
Exposure (1)

Outcome
Not Present
at Start (1)

Assessment (1)

Outcome
Selection

] Assessment of Methodologic Quality for Cohort Studies Using the Ottawa-Newcastle Scoring System
TABLE 2

Figure 2 – Forest plot of impact of treatment on need for reintervention.

Surgical ligation of PDA among children and infants
of . 37 weeks’ gestation resulted in lower rates of reintervention compared with catheter-based techniques.
Although each intervention was associated with a
different spectrum of complications, surgery had a nonsignificant tendency toward higher complication rates.
Surgery also had a longer LOS, whereas cost and procedural times were variable.
In the single RCT examined, patients in the surgery arm
did not require reintervention, whereas 6% required
reintervention in the catheter arm. This reintervention
rate is higher than that described in large case series
examining the efficacy of the Amplatzer occluder.23-26
The higher reintervention rate for catheter-based
therapy in the RCT is echoed in the pooled analysis of

Figure 3 – Forest plot of impact of treatment on complications.
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Length of
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Dates of Data Collection
Study

Catheter Arm
Surgical Arm
Study Characteristics

] Length of Stay and Procedural Time
TABLE 3
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observational studies in which surgical therapy had
significantly decreased odds of requiring reintervention
(pooled OR, 0.12; 95% CI, 0.03-0.42). Complication rates
are low for both surgery and interventional approaches
to PDAs. No complications were reported in either arm
of the RCT, and in the pooled results of observational
studies, surgery had an increased risk of complications
compared with catheter-based therapies (pooled OR,
2.01; 95% CI, 0.68-5.91). This is a nonsignificant
result, but the small numbers leave this finding prone
to type 2 error. The studies in our meta-analysis are primarily observational studies with the risks of selection
bias and publication biases.

Surgical ligation is more effective in closing PDAs but
may be associated with an increased risk of complications.
For subjects undergoing the VATS approach, 4.6% had
complications, compared with 0.7% of patients treated
with catheter-based therapy. The safety and efficacy of
VATS is reported in a number of studies.29-31 In a large
case series of pediatric patients with PDA treated by
VATS, patients suffered no mortality and low morbidity
with 1.3% residual patency.29 Another study from 2011
compared pediatric patients with PDA treated by either
VATS or thoracotomy. No patients required reintervention, but VATS had fewer complications, a lower cost, a
shorter LOS, and a shorter time in the operating room.32
The same authors also compared the outcomes of pediatric and adult PDAs treated either by VATS or by
catheter-based therapy using the Amplatzer occluder
and found that subjects undergoing VATS did not
require reintervention compared with 4.1% in the
catheter arm. VATS also had fewer complications and a
lower cost but an increased duration of procedure and a
longer LOS.33
The variability in cost comparisons is likely multifactorial. Costs vary based on treatment location even when
controlling for currency. In addition, different studies
include different items in their cost analysis. Given these
factors, it is difficult to comment on which treatment
strategy is more cost effective. Other studies comparing
the cost of surgical and catheter-based therapies in
789
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TABLE 4

adult and pediatric patients have demonstrated similar
inconsistencies.34,35
As with all meta-analyses, the quality of pooled results is
dependent on the quality of the data. A major limitation
of this review is the lack of RCTs in the literature. As
anticipated, in the observational studies, there was significant selection bias. Only one study had matched
cohorts based on patient age, sex, weight, and duct size.
The treatment arms of other studies were determined
by patient and surgeon preference. In general, studies
reported that younger patients and patients with larger
or morphologically difficult PDAs were preferentially
placed in the surgical arm as opposed to the catheterbased arm. Furthermore, the largest study in the metaanalysis excluded foreign nationals and patients with
large ducts at the time of catheterization/operation.15 Even
excluding these patients, the loss to follow-up was 30%.
In addition, pooled studies vary in the types of surgical
therapies and catheter-based therapies. Patients treated
with VATS were combined with those treated by thoracotomy, and the various types of catheter-based therapies
were combined. Thus, if a particular approach within
one of these categories is significantly more or less
superior, this will not be apparent in our results. For
the primary outcome of need for reintervention, study
heterogeneity was low, but for complication rates, there
was moderate heterogeneity, limiting the interpretation
of the results.
Because the data in these studies span . 20 years, the
results reflect, to some extent, the outcomes of historical
devices and approaches. Only 20 of the 417 patients in
the catheter-based treatment arm of the observational
studies were treated with the Amplatzer occluder, the

journal.publications.chestnet.org

device used most worldwide.24,27,36,37 A study by
Ghasemi et al9 compared patients who had catheterbased occlusion of their PDAs with patients treated with
a variety of devices, including Gianturco coils, flipper
coils, the Amplatzer occluder, and Nit Occlud coils.
Patients treated by Gianturco and flipper coils had
increased residual shunting compared with those treated
with either the Amplatzer occluder or the Nit Occlud
coils. There were no mortalities, and major complications ranged from 10.9% (Gianturco coils) to 0.7%
(Amplatzer occluder). An additional study of children
with PDAs occluded with either the Amplatzer occluder
or flipper coils had no mortality and low morbidity
rates in both groups; however, the Amplatzer group
had fewer reinterventions.6

Conclusions
Closure of the nonpremature pediatric PDA using surgical therapies is associated with lower reintervention
rates. Whether this comes at a cost of greater complications is unclear. This meta-analysis did not include
premature infants and, thus, the results should not be
generalized to this patient population. VATS for occlusion of PDAs presents an attractive alternative to open
surgical ligation in the appropriately selected patient.
However, few studies have compared VATS with catheterbased therapies, specifically the Amplatzer occluder.
With the evolution of surgical and catheter-based techniques, more large-scale, randomized studies must be
carried out comparing VATS to catheter-based therapy
using the Amplatzer occluder and other new devices.
Studies should further elucidate the optimal treatment
strategy for occluding PDAs in specific patient populations based on age, size, and the morphology of the
PDA.
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